Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 7, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for June 26, 2007 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Baptist Interventional Radiologist Uses Advanced Techniques to Precisely Attack Cancer Tumors, Sees Prolonging of Life

Baptist board certified physicians take multidisciplinary team approach to treating tumors.
Success is not guaranteed, but chemoembolization is the single best therapy for unresectable hepatocellular carcinoma in patients able to tolerate the procedure.

Jackson, MS (PRWEB) June 26, 2007 -- As part of Baptist Health Systems' team of board certified physicians in Jackson, Miss., Interventional Radiologist Timothy Usey, MD, uses state-of-the-art imaging equipment and minimally invasive techniques to deliver cancer-fighting agents to precisely attack tumors. Interventional radiologists are medical doctors using imaging equipment such as fluoroscopy, magnetic resonance (MR) imaging, ultrasound and computed tomography (CT) to diagnose and treat disease. IRs are board certified radiologists, fellowship trained in percutaneous interventions using imaging guidance. Their specialized training is certified by the America Board of Medical Specialties.

"At Baptist, we take a multidisciplinary team approach to treating patients," Dr. Usey said. "We have board-certified physicians, including specialists in surgery, oncology, interventional radiology, gastroenterology, radiation oncology, and pathology to develop and implement the most effective treatment plan for each patient."

While there are many common interventional radiology procedures Dr. Usey performs, he elaborated on the positive results that Baptist physicians are seeing in patients treated with hepatic artery chemoembolization to fight liver tumors. Chemoembolization is a minimally-invasive, image-guided procedure in which cancer-fighting drugs are delivered directly into the blood vessels supplying liver tumors. The technique is primarily used for treating primary liver cancer (hepatocellular carcinoma), as well as metastases from carcinoid tumors and pancreatic islet cell tumors.

"Anytime a patient has a liver tumor, you want to surgically remove it if you can. In those patients with unresectable hepatic malignancies, however, chemoembolization can be amazingly effective in destroying the bulk of the malignant tissue," Dr. Usey explained. "Of course, chemoembolization cannot cure these patients, but we typically see this procedure destroying more than 90 percent of the liver tumor in most patients."

Dr. Usey added that patients who originally presented with a very limited life expectancy are now living three to four years after a diagnosis of advanced hepatocellular carcinoma. "Success is not guaranteed, but chemoembolization is the single best therapy for unresectable hepatocellular carcinoma in patients able to tolerate the procedure."

During chemoembolization, under x-ray guidance, a small catheter is inserted into an artery in the groin. The catheter's tip is threaded into the artery in the liver that supplies blood flow to the tumor. Chemoembolization uses several cancer-fighting drugs which are mixed with particles that embolize, or block, the flow of blood to the diseased tissue.

Radiofrequency ablation is another popular treatment for not only liver cancer, but also many other malignancies elsewhere in the body. It is a procedure that uses electrical currents to generate heat that destroys malignant tissue in the body. It involves inserting a thin needle, guided by imaging techniques such as ultrasound or computed tomography, through the skin (or, in some cases, through a laparoscopic incision) and into the core of a tumor.

"Liver cancer affects a large number of Mississippians," Dr. Usey said. "Effective treatment can be complex, but Baptist has a variety of physicians that come together as a team to offer the best treatment options for the patient and no other health care organization in the state has that."

Dr. Usey is a board certified radiologist, with a certificate of added qualification (CAQ) in interventional radiology, and received his Doctor of Medicine degree from The Johns Hopkins University School of Medicine in Baltimore,MD. He completed his residency at Emory University School of Medicine in Atlanta, GA and fellowship at Washington University School of Medicine in St. Louis, MO.

For more information on Baptist Cancer Services visit http://www.mbhs.org/med_serv/cancer/index.htm or call the Baptist Health Line at 1-800-948-6262.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1IYWxmLUxvdmUtQ291cC1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Robby Channell
Baptist Health Systems
6019746289
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright